I. Kade Karisma Gita Ardana
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: State University of Malang (2018–2022); Universitas Gadjah Mada (2020); Universitas Tribhuwana Tunggadewi (2020); Rumah Sakit Umum Pusat Dr. Sardjito (2020)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
I. Kade Karisma Gita Ardana's research focuses on mesenchymal stem/stromal cells, investigating their behavior and potential applications. Recent work includes assessing the effects of dasatinib on these cells and validating a genomic biomarker for their scalability. Ardana's studies also explore the implications of genotype status on cellular senescence phenotypes in these cells, with particular attention to donor variability and quality assessments. Earlier research examined genetic polymorphisms related to skeletal malocclusions in the Javanese population and salinity tolerance in rice varieties. Ardana has collaborated with researchers at the University of Arkansas at Fayetteville, including Vitali Maldonado and Rebekah M. Samsonraj, and at the University of Arkansas for Medical Sciences, including C. Lowry Barnes.
Metrics
- h-index: 3
- Publications: 14
- Citations: 18
Selected Publications
-
Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes (2026)
-
Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes (2025)
-
Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells (2024)
-
Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells (2024)
Collaboration Network
Top Collaborators
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes
- Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Correction: Assessing the Effects of Dasatinib on Mesenchymal Stem/Stromal Cells
- Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes
- Validation of a Novel Genomic Biomarker of Mesenchymal Stem Cell Scalability and Implications of Genotype Status on Cellular Senescence Phenotypes
- Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes
- Validation of a novel genomic biomarker of mesenchymal stem cell scalability and implications of genotype status on cellular senescence phenotypes
Similar Researchers
Based on overlapping research topics